| 1 |
张丽丽，韩志海，张春阳，等. 纤维化性结缔组织病相关间质性肺疾病进展的危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(3): 434-441.
|
| 2 |
郭丽娅，李浩源，焦以庆，等. 71例具有自身免疫特征的间质性肺炎的临床特点[J/OL]. 中华肺部疾病杂志(电子版), 2020, 13(3): 382-385.
|
| 3 |
Ozasa M, Zaizen Y, Tabata K, et al. Recognition of connective tissue disease-related interstitial pneumonia based on histological score-A validation study of an online diagnostic decision support tool[J]. Diagnostics (Basel), 2021, 11(8): 1359.
|
| 4 |
Shao T, Shi X, Yang S, et al. Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations[J]. Front Immunol, 2021, 12: 684699.
|
| 5 |
Wells AU, Denton CP. Interstitial lung disease in connective tissue disease-mechanisms and management[J]. Nat Rev Rheumatol, 2014, 10(12): 728-739.
|
| 6 |
Papanikolaou IC, Boki KA, Giamarellos-Bourboulis EJ, et al. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases[J]. Immunol Lett, 2015, 163(2): 179-186.
|
| 7 |
Ma R, Ortiz Serrano TP, Davis J, et al. The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease[J]. FASEB J, 2020, 34(10): 13156-13170.
|
| 8 |
Montero P, Milara J, Roger I, et al. Role of JAK/STAT in interstitial lung diseases: Molecular and cellular mechanisms[J]. Int J Mol Sci, 2021, 22(12): 6211.
|
| 9 |
Manfredi A, Luppi F, Cassone G, et al. Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia[J]. Expert Rev Clin Immunol, 2020, 16(8): 751-770.
|
| 10 |
Zhang S, Zheng R, Pan Y, et al. Potential therapeutic value of the STING inhibitors[J]. Molecules, 2023, 28(7): 3127.
|
| 11 |
Wu J, Mei C, Luo Z, et al. Efficacy and safety of JAK inhibitors in connective tissue disease-associated interstitial lung disease[J]. Chin Med J (Engl), 2025, 138(1): 1-4.
|
| 12 |
Editorial Office. Erratum to patterns of lung fibrosis in patients with interstitial pneumonia with autoimmune features and connective tissue diseases-associated interstitial lung disease-a narrative review[J]. Ann Palliat Med, 2022, 11(12): 3846-3847.
|
| 13 |
Tseng CC, Sung YW, Chen KY, et al. The role of macrophages in connective tissue disease-associated interstitial lung disease: Focusing on molecular mechanisms and potential treatment strategies[J]. Int J Mol Sci, 2023, 24(15): 11995.
|
| 14 |
Liu M, Zeng X, Wang J, et al. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis[J]. Stem Cell Res Ther, 2016, 7(1): 63.
|
| 15 |
Yoo H, Hino T, Hwang J, et al. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management[J]. Eur J Radiol Open, 2022, 9: 100419.
|
| 16 |
Yang S, Wang J, Sun D, et al. Disease progression in patients with usual interstitial pneumonia and probable UIP patterns on computed tomography with various underlying etiologies: a retrospective cohort study[J]. Front Med (Lausanne), 2023, 10: 1246767.
|
| 17 |
Dong F, Zheng L, An W, et al. A meta-analysis of the clinical significance of neutrophil-to-lymphocyte ratios in interstitial lung disease[J]. PLoS One, 2023, 18(6): e0286956.
|
| 18 |
Karampitsakos T, Woolard T, Bouros D, et al. Toll-like receptors in the pathogenesis of pulmonary fibrosis[J]. Eur J Pharmacol, 2017, 808: 35-43.
|
| 19 |
Yeh FC, Chen CN, Xie CY, et al. TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension[J]. Eur Respir J, 2023, 62(1): 2300204.
|
| 20 |
Gu BH, Madison MC, Corry D, et al. Matrix remodeling in chronic lung diseases[J]. Matrix Biol, 2018, 73: 52-63.
|
| 21 |
Bhattacharyya S, Wang W, Morales-Nebreda L, et al. Tenascin-C drives persistence of organ fibrosis[J]. Nat Commun, 2016, 7: 11703.
|
| 22 |
Renaud L, da Silveira WA, Takamura N, et al. Prominence of IL6, IGF, TLR, and bioenergetics pathway perturbation in lung tissues of scleroderma patients with pulmonary fibrosis[J]. Front Immunol, 2020, 11: 383.
|
| 23 |
Song Y, Zhou W. Role of TLR7 in the pathogenesis of primary Sjögren′s syndrome[J]. Clin Exp Rheumatol, 2024, 42(12): 2513-2519.
|
| 24 |
Wang Y, Roussel-Queval A, Chasson L, et al. TLR7 signaling drives the development of Sjögren′s syndrome[J]. Front Immunol, 2021, 12: 676010.
|
| 25 |
王宜艳，陈伟. 基于TLR4/MyD88/TRIF通路探讨芪参合剂对耐药肺炎克雷伯菌脓毒症大鼠的固有免疫调节机制[J]. 中国免疫学杂志，2021, 37(2): 161-166.
|
| 26 |
Margaritopoulos GA, Lasithiotaki I, Antoniou KM. Toll-like receptors and autophagy in interstitial lung diseases[J]. Eur J Pharmacol, 2017, 808: 28-34.
|
| 27 |
Cerro Chiang G, Parimon T. Understanding interstitial lung diseases associated with connective tissue disease (CTD-ILD): Genetics, cellular pathophysiology, and biologic drivers[J]. Int J Mol Sci, 2023, 24(3): 2405.
|
| 28 |
Effendi WI, Nagano T. The crucial role of NLRP3 inflammasome in viral infection-associated fibrosing interstitial lung diseases[J]. Int J Mol Sci, 2021, 22(19): 10447.
|
| 29 |
Wissinger E, Goulding J, Hussell T. Immune homeostasis in the respiratory tract and its impact on heterologous infection[J]. Semin Immunol, 2009, 21(3): 147-55.
|
| 30 |
Hagiwara AM, Moore RE, Wallace DJ, et al. Regulation of cGAS-STING pathway-implications for systemic lupus erythematosus[J]. Rheumatol Immunol Res, 2021, 2(3): 173-184.
|
| 31 |
Wang J, Dai M, Cui Y, et al. Association of abnormal elevations in IFIT3 with overactive cyclic GMP-AMP synthase/stimulator of interferon genes signaling in human systemic lupus erythematosus monocytes[J]. Arthritis Rheumatol, 2018, 70(12): 2036-2045.
|
| 32 |
You R, He X, Zeng Z, et al. Pyroptosis and its role in autoimmune disease: A potential therapeutic target[J]. Front Immunol, 2022, 13: 841732.
|
| 33 |
Keskitalo S, Haapaniemi E, Einarsdottir E, et al. Novel TMEM173 mutation and the role of disease modifying alleles[J]. Front Immunol, 2019, 10: 2770.
|
| 34 |
Shen S, Hu M, Peng Y, et al. Research progress in pathogenesis of connective tissue disease-associated interstitial lung disease from the perspective of pulmonary cells[J]. Autoimmun Rev, 2024, 23(7-8): 103600.
|
| 35 |
Deng J, He Y, Sun G, et al. Tanreqing injection protects against bleomycin-induced pulmonary fibrosis via inhibiting STING-mediated endoplasmic reticulum stress signaling pathway[J]. J Ethnopharmacol, 2023, 305: 116071.
|
| 36 |
丁慧晴，周玉莹，印旨意，等. cGAS-STING通路在代谢性心血管疾病中的作用[J]. 中南大学学报(医学版), 2023, 48(7): 1086-1097.
|
| 37 |
Yoon HY, Park JS, Lee SE, et al. Circulating mitochondrial DNA as a biomarker of survival in rheumatoid arthritis-associated interstitial lung disease[J]. Eur Respir J, 2023, 61(1): 2201984.
|
| 38 |
Kuriyama Y, Shimizu A, Kanai S, et al. Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease[J]. Sci Rep, 2021, 11(1): 23146.
|